{
    "title": "Glaxo boosted as US regulators approve new - one tablet a day - HIV treatment",
    "url": "https://www.dailymail.co.uk/money/markets/article-5108691/Glaxo-boosted-regulators-approve-new-HIV-treatment.html",
    "date": "2017-11-22",
    "keywords": [
        "share",
        "hiv",
        "drug",
        "treatment",
        "fund",
        "food",
        "administration",
        "light",
        "virus",
        "tax",
        "investment",
        "account",
        "fee",
        "glaxosmithkline",
        "boost",
        "treatmentthe",
        "walmsley",
        "medicine",
        "revenue",
        "gap",
        "advair",
        "budget",
        "bill",
        "rate",
        "income",
        "stock",
        "exchange",
        "boss",
        "case",
        "rolet",
        "city",
        "rbs",
        "sale",
        "stake",
        "sea",
        "bid",
        "article",
        "threeinone",
        "inhaler",
        "lung",
        "disease",
        "juluca",
        "tablet",
        "rilpivirine",
        "course",
        "monthsjuluca",
        "healthcare",
        "pfizer",
        "shionogi",
        "gsk",
        "cent",
        "diy",
        "capital",
        "risk",
        "isa",
        "trade",
        "month",
        "community",
        "model",
        "affiliate",
        "product",
        "money",
        "commission",
        "editorial",
        "independence",
        "investing",
        "platform"
    ],
    "category": [
        "money",
        "markets"
    ]
}